<<
>>

3.5. An estimation of dynamics of average concentration of haemoglobin at children with JURA, receiving various variants of therapy

Also dynamics of average concentration of haemoglobin at children with juvenilnym a pseudorheumatism complicated by an anaemia, receiving various variants of therapy JURA has been estimated. Dynamics was estimated on time (in weeks) achievements of target level of average concentration of haemoglobin - 120 g/l.

At children suffering juvenilnym by a pseudorheumatism and an anaemia, and receiving therapy totsilizumabom average concentration of haemoglobin at the moment of the treatment beginning has made 101 g/l. And at children receiving therapy golimumabom and standard therapy juvenilnogo a pseudorheumatism the haemoglobin average level has appeared peer 105 g/l.


In all groups positive dynamics of average concentration of haemoglobin against spent therapy becomes perceptible.

In group of children receiving totsilizumab achievement of target average concentration of haemoglobin, it becomes perceptible by 7 week from the moment of the first introduction of a preparation.

In group of children receiving golimumab achievement of average concentration of haemoglobin of 120 g/l it becomes perceptible in 10 weeks after the treatment beginning.

The slowest dynamics of average concentration of haemoglobin becomes perceptible in group of children receiving standard therapy juvenilnogo of a pseudorheumatism. Achievement of target concentration of haemoglobin becomes perceptible on 34 week.

Thus, the greatest average rate of augmentation of concentration of haemoglobin becomes perceptible in group of children receiving therapy totsilizumabom and makes 2,7 g/l in a week. In group of the patients receiving golimumab rate of augmentation of average concentration of haemoglobin, has made 1,5 g/l in a week. And in group of children receiving standard therapy juvenilnogo of a pseudorheumatism rate of augmentation of average concentration of haemoglobin it has appeared the least and has made 0,4 g/l in a week. Results of research are presented in a drawing 3.12.

Drawing 3.12. Dynamics of average concentration of haemoglobin at children with JURA, receiving various variants of therapy

<< | >>
Scientific source EGOROV Andrey Sergeevich. THE GEPSIDIN-INTERLEUKIN-6 SYSTEM AS A FACTOR FOR MANAGING THE COURSE OF ANEMIA IN CHRONIC ARTHRITIS IN CHILDREN DISSERTATION for the degree of candidate of medical sciences. St. Petersburg - 2016. 2016

Скачать оригинал источника
Помощь с написанием учебных работ

Other medical related information 3.5. An estimation of dynamics of average concentration of haemoglobin at children with JURA, receiving various variants of therapy:

  1. THE TABLE OF CONTENTS
  2. Clinico-laboratory indicators at treatment of a chronic arthritis with use of biological therapy
  3. 3.5. An estimation of dynamics of average concentration of haemoglobin at children with JURA, receiving various variants of therapy
  4. THE CONCLUSION
  5. 5.2. Dynamics of indicators of clinical implications at children.
  6. Dynamics of the given functional changes nervous sisyotemy at children with perinatalnymi encephalopathies in katamnesticheyo skom observation.
  7. infantile intestinal gripes
  8. Results of an estimation tsitokinovogo a profile of blood serum at surveyed children
  9. Infliksimab
  10. Chapter 3.3. Efficiency and safety abatatsepta at children with JUIA.